FGFR4 and metabolic dysfunction-associated steatotic liver disease: According to Nobili et al., in children with NAFLD, hepatic FXR and circulating FGF19 levels were lower than those in control subjects, decreasing FGFR4 signaling and promoting NAFLD [90].